33.2. Analysis.
Comparison 33: Esketamine versus placebo (pre‐planned sensitivity analysis: excluding studies that included participants with bipolar disorder or psychotic features), Outcome 2: Remission rate
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.